Brief: Ironwood Pharmaceuticals Q4 Revenue USD 117.553 Million Vs. IBES Estimate USD 117.5 Million
15/02/2024 12:00
Feb 15 (Reuters) - Ironwood Pharmaceuticals Q4 adjusted net income USD 39 thousand. * Q4 adjusted EBITDA USD 39.895 million * Q4 operating expenses USD 79.964 million * Q4 net income USD -1.745 million
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation